HIMSS16 Presentation Highlights the Role of Wolters Kluwer ProVation Order Sets in Standardizing Care During a Public Health Crisis

MINNEAPOLIS--(BUSINESS WIRE)--The Health division of Wolters Kluwer, a leading global provider of information and point of care solutions for the healthcare industry, announced today that Rabin Pant, director of clinical informatics with Methodist Health System, will present a session at HIMSS16 highlighting the critical role of effective point of care clinical content management during a public health crisis. The session titled “The Value of Standardized Care in a Public Health Crisis” will demonstrate how ProVation® Order Sets, powered by UpToDate® Decision Support enabled the organization to lay a foundation of highly-reliable, evidence-based clinical care during the health system’s response to the 2014 Ebola outbreak in Dallas.

While standardization of industry best practices is a focal point of national quality initiatives, one of the greatest challenges clinicians faced when Ebola entered the U.S. was lack of standardized protocols based on the latest clinical evidence. Pant will provide insight into how Dallas-based Methodist Health System quickly marshalled its existing clinical content management infrastructure and governance process to create a foundation of high reliability, ensuring high adoption of standardized best practices that minimized the potential for panic or error.

“The Value of Standardized Care in a Public Health Crisis” is scheduled for March 1 at 4 p.m. in the Human Nature Theater of the Sands Expo Convention Center in Las Vegas.

A vital component of a healthcare organization’s care alignment strategy, ProVation Order Sets is driven by a collaborative, web-based system for authoring, review, updating and approval and powered by the trusted content of UpToDate and Lippincott Solutions®. ProVation Order Sets streamlines cumbersome governance processes and helps providers adopt evidence-based medicine at the point of care to speed compliance with an expanding array of quality measures driving reimbursement. Customers realize a fast return on investment through optimized reimbursements and lower costs enabled by streamlined processes and improved efficiencies.

“In today’s quality-driven healthcare landscape, health systems must have a foundation of best-practice guidance in place to support rapid and effective response to a public health crisis, when time is of the essence to contain potentially deadly outbreaks,” said David A. Del Toro, President & CEO of Clinical Software Solutions at Wolters Kluwer. “The clinical content infrastructure offered through ProVation Order sets equips organizations with the tools needed to ensure best practice protocols are followed and care delivery is optimized.”

Wolters Kluwer will feature ProVation Order Sets in Booth #5537 at HIMSS16, which takes place February 29 through March 4 at the Sands Expo Convention Center in Las Vegas.

About Wolters Kluwer
Wolters Kluwer is a global leader in professional information services. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance and healthcare rely on Wolters Kluwer's market leading information-enabled tools and software solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.

Wolters Kluwer reported 2014 annual revenues of €3.7 billion. The group serves customers in over 170 countries, and employs over 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

 

Wolters Kluwer Health is a leading global provider of information and point of care solutions for the healthcare industry. For more information about our products and organization, visit http://www.wolterskluwer.com/, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.